RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Hudson Therapeutics, Inc., a biotechnology company specializing in anti-inflammatory and immuno-oncology drugs, announced that Janice Marie McCourt has been appointed to co-Chief Executive Officer and a member of the Hudson Board of Directors, effective October 30, 2023...